Evidence map›Paper›PMID 29872679›Full record

ReviewInternational journal of women's dermatology2018

A review of diagnosis and treatment of acne in adult female patients.

A U Tan, B J Schlosser, A S Paller

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of women's dermatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05982613 (Effectiveness of Standard Therapy of Acne Vulgaris Based on Clinical Practice Guidelines), which is not on this map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05982613 completednot on this mapstarted 2023, after this paper: background citation

Effectiveness of Standard Therapy of Acne Vulgaris Based on Clinical Practice Guidelines (CPG) in Indonesia

TypeobservationalSponsorIndonesia UniversityRan2023 to 2023Enrolled724ConditionsAcne Vulgaris
3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 239 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Safety and effectiveness of topical dapsone in acne treatment: A review.Journal of family medicine and primary care · 2026
    Review
  7. Selective Modulation ofClinical, cosmetic and investigational dermatology · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Molecular pharmaceutics · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

A U TanNorthwestern University, Department of Dermatology, Chicago, IL.
B J SchlosserNorthwestern University, Department of Dermatology, Chicago, IL.
A S PallerNorthwestern University, Department of Dermatology, Chicago, IL.
Northwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review focuses on the treatment options for adult female patients with acne. Acne in adult female patients may start during adolescence and persist or have an onset in adulthood. Acne has various psychosocial effects that impact patients' quality of life. Treatment of acne in adult women specifically has its challenges due to the considerations of patient preferences, pregnancy, and lactation. Treatments vary widely and treatment should be tailored specifically for each individual woman. We review conventional therapies with high levels of evidence, additional treatments with support from cohort studies and case reports, complementary and/or alternative therapies, and new agents under development for the treatment of patients with acne.

Identifiers

PMID29872679
PMCPMC5986265
OpenAlexW2778012448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.